Both intermittent fasting and cutting calories every day can be hard to stick to and may not be safe for everyone with type 2 diabetes, so neither is a perfect solution—this is based on the abstract summary—full study details were not available.
Evidence from Studies
Supporting (1)
Community contributions welcome
The study looked at two diet plans for type 2 diabetes—intermittent fasting and cutting calories every day—and found both can help, but both also have downsides that make them hard for some people to stick with long-term.
Contradicting (0)
Community contributions welcome
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Comprehensively evaluate the safety, adherence, and dropout rates across multiple high-quality trials of both dietary approaches.
A systematic review of RCTs lasting ≥6 months, assessing adverse events, hypoglycemia rates, dropout percentages, and patient-reported adherence in adults with type 2 diabetes on intermittent fasting vs. continuous restriction, with meta-analysis of safety outcomes.
Provide causal evidence on adherence and safety differences between the two diets.
A 12-month RCT with 500 participants aged 40-70 with type 2 diabetes, comparing 5:2 intermittent fasting to 25% daily caloric restriction, with structured monitoring of hypoglycemia, medication adjustments, quality of life, and retention rates as primary safety and adherence outcomes.
Reveal current patterns of use, perceived challenges, and safety concerns among individuals with type 2 diabetes practicing either diet.
A national survey of 3,000 adults with type 2 diabetes, assessing current or past use of intermittent fasting or calorie restriction, reasons for starting/stopping, hypoglycemia episodes, and healthcare provider guidance, analyzed by demographic and clinical subgroups.